ABSTRACT -Chronic toxicity and carcinogenicity of catechin mixture were examined in Wistar Hannover GALAS rats. Administration was in the diet at concentrations of 0, 0.02, 0.3, 1 or 3%. Slight increases in relative liver weight and centrilobular hypertrophy of hepatocytes associated with induction of CYP3A2 were found at the 3% in males of both studies. However, because there were no signs indicative of hepatotoxicity on serum biochemical and histopathological examinations, the changes observed in the liver were regarded as adaptation, and not adverse effects. The slight depressions of body weights at the 3% in females of the chronic toxicity study and in both sexes of the carcinogenicity study were observed. These decreases were because the diet at the highest concentration was frangible and nominal food consumption may not have reflected the actual food consumption resulting in decrease in caloric intake, rather than toxic effects. Thus it was concluded that catechin mixture had no toxicity. In addition, tumor incidences and types were comparable between treated and control groups. Based on the results, the no observed adverse effect levels estimated from the chronic toxicity study were 3% in both sexes equal to 1922.9 in males and 2525.7 mg/kg/day in females. Catechin mixture has no carcinogenic potential in male and female rats.
INTRODUCTION
Green tea is consumed as a popular beverage in Japan and throughout the world. During the past decade, epidemiological studies have shown the tea catechin intake is associated with lower risk of cardiovascular disease (Hertog et al., 1993) . In vitro biochemical studies prevent oxidation of low-density lipoprotein (LDL), which is recognized as an important step in the formation of atherosclerotic plaques and subsequent cardiovascular disease (de Whally et al., 1990; Steinberg et al., 1989) . In addition, catechin has been known to have protective effects against some common types of cancer (Adhami et al., 2003; Doss et al., 2005; Stuart et al., 2006; Kumar et al., 2007) . Epidemiological studies have indicated that Asian populations that consume tea on a regular basis have lowest incidence of many types of cancer including prostate cancer, than their western counterparts (Jian et al., 2004; Sim and Cheng, 2005; Siddiqui et al., 2006) .
The main catechin mixutre found in green tea are (-)-epicatechin (EC), (-)-epigallocatechin (EGC), (-)-epicatechin-3 gallate (ECG), and EGCG. Among these, EGCG is the most abundant and has attracted the most attention with respect of anticarcinogenic activity (Doss et al., 2005) . There is vast amount of scientific literature which suggests that EGCG is responsible for the majority of the potential health benefits attributed to green tea consumption (Khan et al., 2008) . Regarding chemopreventive mechanisms, inhibition of activation of specific receptor tyrosine kinases (RTKs) (Shimizu et al., 2008) and related signaling pathways (Verschoyle et al., 2007) or apoptosis induction (Khan et al., 2006 (Khan et al., , 2010 Yang et al., 2002) have been focuses of attention.
As agents considered to be beneficial and may be expected to be ingested over prolonged period, chronic exposure information is needed. However, the safety information available for catechin is limited. In Ames tests, catechins showed positive effects with or with-out cytotoxic levels (Takabe, 1997, Unpublished data). On the other hand, other genotoxicity studies concluded that catechin had no potential of genotoxicities to organisms in Ames, micronucleus, and chromosomal abbreviation tests (Sofuni, 1997 Unpublished data; Kurita, 1997 Unpublished data). In a subchronic study, data suggesting slight effects of catechin mixture on the liver were obtained without any morphological changes at dietary concentration of 5% (Takami et al., 2008) . However, information of chronic toxicity or carcinogenicity in rodents is lacking. Although many experimental and epidemiological data supports beneficial effects on human health described above, the controversial effects for genotoxicity are concern. Therefore, the present study was conducted to clarify the chronic toxicity and/or carcinogenicity of catechin mixture with oral administration of Wistar Hannover GALAS rats for 12 and 24 months. In addition, components of catechin mixture in the prepared diet were analyzed.
MATERIALS AND METHODS

Animals
Male and female specific-pathogen-free Wistar Hannover GALAS rat (BrlHan:WIST@Jcl Clea, Tokyo, Japan) at 5 weeks of age were used after 1-week acclimatization period. This strain rat has been recently distributed for international standardization of preclinical and toxicological research. The animals had free access to basal diet (CRF-1, Oriental Yeast Co. Ltd., Tokyo, Japan) and tap water during the acclimatization period. They were housed three per plastic cage with sterilized soft paper chips as bedding in a barrier-maintained animal room at 24 ± 1°C and 55 ± 5% and showing no abnormalities were used at 6 weeks of age. The protocol of the experiment was reviewed and approved by the Ethical Committee of Sasaki Institute (Tokyo, Japan).
Chemicals, dose selection, preparation of diet, and analysis of chemicals.
Catechin was supplied by TAIYO Kagaku Co. Ltd. (Mie, Japan) as catechin mixture produced by 3 companies (TAIYO KAGAKU, CO., LTD., MITSUI NORIN, CO.,LTD. Tokyo, Japan and ITOEN, LTD., Tokyo, Japan). The concentration of each component in the catechin mixture was analyzed at the beginning of study (Table 1) . Treated doses in the present study were based on the results of 90-day dietary subchronic study in rats (Takami et al., 2008) . In this study, the over 10% depression of body weights in males and effect on the liver were observed in both sexes at 5%, the highest dose. Although no related histopathological abnormalities were detected, the study indicated that the concentration of 5% might be greater than the maximum tolerance dose (MTD) in males. Therefore, we chose dietary concentrations of 0, 0.02, 0.3, 1 or 3% in the present study. The lowest dose, 0.02% was considered to be an equivalent to the exposure levels of people consuming in a bottle of green 1.8960 ± 0.3016 0.0055 ± 0.0022 1.5110 ± 0.5879 GC, gallocatechin; C, catechin; EGCG, (-)-epigallocatechin-3-gallate; EC, (-)-epicatechin; GCG, gallocatechin; EGC, (-)-epigallocatechin; ECG, (-)-epicatechin-3 gallate; CG, catechin gallate. tea in Japan.
Powder basal diet (CRF-1, Oriental Yeast) mixed with catechin mixture at designated concentrations was pelleted and was given rats ad libitum. Analysis of dietary concentration of each catechin component in prepared diet was performed using each lot. The control animals received basal diet (CRF-1) pelleted in the same way. Stability of dietary catechin mixture and each component up to 2 months after preparation was confirmed. The analyzed concentrations and stabilities of test materials in the diets were found to be generally acceptable (data not shown). The average concentrations of catechin mixture, caffeine and total polyphenols in the control and all treated groups were analyzed at diet preparation (Table 1) .
Combined chronic/carcinogenicity study
The present study was designed as a combined oneyear toxicity/carcinogenicity study in accordance with guidelines for designation of food additives and for revision of standards for use of food additives, Ministry of Health Labour and Welfare, Japan (MHLW, 1996) . Details of the study protocol were as follows:
Chronic toxicity study
Rats were randomly allocated to 5 groups, each consisting of 10 males and 10 females, and given the pellet diet described above for 12 months. Throughout the study, rats had free access to tap water.
The animals were observed daily for clinical signs and mortality. Body weights and food consumption were recorded every week until week 12 and every 4 weeks thereafter. After 12 months treatment, urinalysis was conducted for all animals using test paper (Pretest, Wako Pure Chemical, Ltd., Osaka, Japan), and all rats were euthanized under deep anesthesia after on overnight fast. Blood samples were collected from the abdominal aorta for hematology and serum biochemistry. Hematological examination was performed using automatic hematology analyzer, M-2000 (Toa-Medical Electronics, Hyogo, Japan), and parameters for serum biochemistry were analyzed at SRL, Inc. (Tokyo, Japan) using sera frozen after centrifugation (3,000 rpm for 10 min.) After complete macroscopic examination, the brain, pituitary, heart, spleen, liver, adrenals, kidneys, testes or ovaries and prostate or uterus were weighed. In addition, the nasal cavity, eyes, Harderian glands, spinal cords (cervical, thoracic, and lumbar portions together with corresponding vertebral bones), salivary glands, stomach, small and large intestines, pancreas, urinary bladder, skin, mammary gland, mesenteric lymph nodes, trachea, lungs, esophagus, thyroid glands, tongue, thigh muscle, sciatic nerve, epididymis, seminal vesicles, prostate, uterus, ovaries, and vagina were also removed. All organs/ tissues were fixed in 10% neutral buffered formalin except for testes fixed in Bouin's solution overnight. Bone such as the nasal cavity, spinal column with spinal cords, sternum, and femur were decalcificated. After routine processing for paraffin embedding, sectioning and staining with hematoxylin and eosin, histological assessment was performed for all tissues of all animals.
To clarify immunohistochemical distribution of cytochrome P450s in the hypertrophied hapatocytes, serial liver sections in the 0 and 3% group of both sexes were incubated with anti-rat CYP1A1, 1A2 and 3A2 antibodies (Daiichi Chemicals, Tokyo, Japan), diluted 1:100 in Tris-buffered solution (Takara Bio, Shiga, Japan) with 1% skim milk at 37°C for 1 hr. After the incubation, the sections were exposed to secondary antibodies and linked with streptavidin peroxidase using a DAKO LSAB+ kit (DAKO cytomation, California, CA, USA). The binding was visualized by 3, 3'-diaminobenzidine tetrahydrochloride (Wako Pure Chemicals).
Carcinogenicity study
Rats were randomly allocated to 5 groups, the same doses as the chronic study, each consisting of 50 males and 50 females. The animals were housed three or four per plastic cage, and were given the prepared pellets at each dose for 24 months. Clinical observation and measurements of body weights and food consumption were conducted in the same manner as for the chronic study. After 24 month treatment, all surviving animals were euthanized under deep anesthesia, and the liver were resected and weighed. All organs and/or tissues listed above, as well as macroscopic masses and any abnormalities were examined macroscopically and microscopically as in the chronic study. Moribund or dead animals were also completely necropsied and pathologically examined to determine their cause of death.
Statistical analysis
In multiple comparisons continuous data were analyzed with Bartlett test. If the variance was homogeneous, the data were assessed by the Dunnett's multiple comparison test. If not, the Steel's multiple comparison test was employed. The histopathology data were employed with Fisher's exact or chi-square test. The level of significance was set at p < 0.05 and 0.01.
RESULTS
General condition and mortality
No treatment-related clinical signs or deaths were found throughout the feeding period in either chronic or carcinogenicity studies (Fig. 1) . The mortalities at termination of the carcinogenicity study were 36, 38, 32, 26 and 22% in males, and 28, 38, 28, 30 and 30% in females of the 0, 0.02, 0.3, 1.0 or 3% group, respectively.
Body weights in the chronic and carcinogenicity studies
In the chronic toxicity study, changes in body weights were comparable among the treated and control animals in males (Fig. 2) . In females, suppression or a tendency for suppression of body weight gain by approximately 15% was observed several times at 3% only after Week 25 (Fig. 2 ). In the carcinogenicity study, suppressions of body weights within 10% was detected in both of males and females receiving the 3% dose in the latter half of the study (Fig. 3) . No changes in body weights were observed in other treated groups.
Food consumption and chemical intakes in the chronic and carcinogenicity studies
The concentrations of catechin mixture in the prepared diet showed a dose dependent increase in the 0.3% group and higher (Table 1) . Their concentrations were comparable between the control and the lowest dose groups. Data for food consumption are summarized in Figs. 4 (chronic study) and 5 (carcinogenicity study) and intakes of catechin mixture is Table 2 . In both studies, increases or tendencies for increased food consumption were observed in males and females at 3%, especially at beginning of the studies. Since the pellets in the 3% group were more frangible than them in other treated or control groups, there were more pellet fragments in the cages of both sexes at 3% compared to other groups. The chemical intakes were shown in Table 2 . Hematology and serum biochemistry Although some significant changes were detected in hematology and blood biochemistry, no obvious doserelation was found for any parameters among the treated groups (Tables 3 and 4) .
Organ weights
In the chronic toxicity study, no significant changes were noted in the absolute and/or relative organ weights except an increase in the relative liver weight in males of the 3% group (Table 5) . In carcinogenicity study, the liver weights in all treated groups were comparable to those of the control group in both sexes (Table 7) . 
Necropsy and histopathology
In the chronic toxicity and carcinogenicity studies, no treated related macroscopic changes were detected. Microscopically, a number of non-neoplastic lesions were observed in both studies. In the chronic study, slight centrilobular hypertrophy of hepatocytes was significantly increased in males at 3% (Table 6, Fig. 6 ). However, this change was not observed in females at 3% or in the other treated groups. In immunohistochemistry, CYP3A2 expression was found in the hypertrophied hepatocytes in males at 3% (Fig. 6) , and any other changes except CYP3A2 were not detected. In the carcinogenicity study, similar mild hepatocellular hypertrophy was also observed in males at the same dose (Table 7) .
In both studies, a number of non-neoplastic changes were detected, but their incidences and severities were similar to those in the control groups, and therefore no dose-related non-neoplastic changes except liver hypertrophy were detected. In the chronic toxicity study, several tumors were detected in all groups including the controls in both sexes. Their incidences were comparable between the control and treated groups in both sexes (Table 6 ). In the carcinogenicity study, a number of tumors were found in many organs and/or tissues in both sexes in all groups (Table 8) . All of the incidences in the treated groups were comparable to those in controls in both sexes. There were several types of tumors showing high incidences such as C-cell adenoma in the thyroid, islet cell adenoma, endometrial stromal polyp or mammary tumor (fibroadenoma and adenocarcinoma). The most common tumor was the anterior adenoma in the pituitary, which was also major cause of death in the present study. In addition thymoma and/or malignant thymoma with lymphocyte proliferation were detected in all groups including controls with similar incidences.
DISCUSSION
The present examination of the chronic toxicity and carcinogenicity of catechin mixture, used as a food additive, in Wistar Hannover GALAS rats showed no effects at concentrations of 0, 0.02, 0.3, 1 or 3% except with regard to body weights, food consumption and hepatocellular hypertrophy at the highest dose. No changes indicating carcinogenic potential were detected.
The food consumption increased or showed a tendency of increase in both sexes of the chronic toxicity and carcinogenicity studies at 3%. In the same dose group depressed body weight gain was observed in females of chronic toxicity study, and both sexes in carcinogenicity study. As for nutritional effects, the caloric contribution of catechin mixture in feed might be low because consistent dose-dependent increase of body weights was lacking. No obvious toxicities were detected in terms of other parameters. In addition, the pellet of 3% was more frangible, but long-term effects of catechin mixture on feeding behavior with continuous dietary administration were not observed. Therefore, the body weight depressions at 3% are considered not to be a toxic effect, but rather a secondary effect resulting from decreased caloric intake. Namely, these decreases were because the diet at the highest concentration was frangible and nominal food consumption may not have reflected the actual food consumption resulting in decrease in caloric intake, rather than toxic effects. Similar suppression of body weights was also noted in males of the 5% group in the subchron- Vol. 36 No. 3 ic study (Takami et al., 2008) .
Histopathologically slight centrilobular hypertrophy of hepatocytes associated with induction of CYP3A2 was found at 3% in males of both studies, and relative weights of the liver increased were limited to the chronic toxicity study. However, no signs indicative of hepatotoxicity were seen in the serum biochemical and histopathological examinations in either study. Therefore, the changes observed in the liver were considered to be treatment-related but not adverse in nature. They might be regarded as adaptation. A joint FAO and WHO meeting of pesticides, residues concluded that in the absence of histopathological damage and relevant clinical chemistry changes at a dose inducing only hepatocellular hypertrophy and/or liver size/weight changes, hypertrophy should not be identified as an adverse effects as a general principle in the final assessment of the liver hypertrophy (JMPR, 2006) . Large doses of many dietary supplements including green tea are reported to induce cytochrome P450s in rats (Jang et al., 2004) . In an earlier study administration of 2% green tea supplement in drinking water for 3 days induced CYP1A2 but not 3A2 (Jang et al., 2004) . Although the reasons for the discrepancy with the present study are not clear, the ingredients of the supplement in the previous study might have differed from those in the present study, because details were not given (Jang et al., 2004) .
In the present carcinogenicity study, none of the treated groups showed a significant increase in the incidence of any specific tumors compares with the corresponding control ones, and also there were no positive trend in both sexes, clearly indicating no carcinogenic potential of long-term treatment with catechin mixture in rats. All the tumors observed in the present study are known to occur spontaneously in aged rats.
Green tea has been consumed as a popular beverage in Japan and throughout the world for many years. During the past decade, epidemiological studies have shown tea catechin intake to be associated with lower risk of cardiovascular disease (Hertog et al., 1993) , or protective effects against some common types of cancer including in the prostate (Adhami et al., 2003; Doss et al., 2005; Jian et al., 2004; Kumar et al., 2007; Siddiqui et al., 2006; Sim and Cheng, 2005; Stuart et al., 2006) . These experimental and epidemiological data might indicate that intake of tea catechin is favorable to human health under appropriate consumption conditions. Many studies reported that EGCG is responsible for the majority of the potential health benefits attributed to green tea consumption (Khan et al., 2008) and this was in fact contained as a major component in the test material in the present study.
Based on the results in the present study, we conclude that catechin mixture has no appreciable toxicity in Wistar Hannover GALAS rats. The no observed adverse effect levels estimated form the chronic toxicity study were 3% in both sexes equal to 1922.9 and 2525.7 mg/kg/day in males and females, respectively. No carcinogenic potential was found in male and female rats fed catechin mixture for 2 years. 
